Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA to Reduce Bruising After Hyaluronic Acid Filler Injection
NCT06665594Phase 2Recruiting
- Sponsor
- University of Wisconsin–Madison
- Start
- Dec 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tranexamic acid in contusion, pain, sponsored by University of Wisconsin–Madison. Started Dec 2025; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
contusionpain
Beyond the preview
Go deeper on NCT06665594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06665594.